14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Hold
Today CTMX ranks #6679 as hold candidate. Get a Free Stock at Robinhood
Stronger Stock

CytomX Therapeutics Stock Forecast NASDAQ:CTMX

$4.36 (-0.23%)

Volume: 570k

Closed: Jan 26, 2022

Hollow Logo Score: -0.709

CytomX Therapeutics Stock Forecast

$4.36 (-0.23%)

Volume: 570k

Closed: Jan 26, 2022

Score Hollow Logo -0.709

CytomX Therapeutics Stock Price (Quote) NASDAQ:CTMX

$4.36 ( -0.23% ) Wednesday, 26th Jan 2022

Range Low Price High Price Comment
30 days $3.67 $4.64 Wednesday, 26th Jan 2022 CTMX stock ended at $4.36. This is 0.23% less than the trading day before Tuesday, 25th Jan 2022. During the day the stock fluctuated 7.18% from a day low at $4.32 to a day high of $4.63.
90 days $3.67 $7.53
52 weeks $3.67 $10.05

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
2022-01-26 $4.40 $4.63 $4.32 $4.36 570 146
2022-01-25 $4.24 $4.43 $4.17 $4.37 658 614
2022-01-24 $4.23 $4.42 $4.04 $4.39 1 121 733
2022-01-21 $4.12 $4.38 $4.10 $4.29 947 278
2022-01-20 $4.24 $4.33 $4.09 $4.16 930 793
2022-01-19 $3.87 $4.16 $3.83 $4.08 1 055 077
2022-01-18 $4.18 $4.28 $3.83 $3.83 1 165 206
2022-01-14 $3.70 $3.95 $3.67 $3.95 720 976
2022-01-13 $3.77 $3.87 $3.68 $3.74 716 738
2022-01-12 $4.02 $4.02 $3.75 $3.76 668 341
2022-01-11 $3.92 $4.08 $3.86 $3.98 747 974
2022-01-10 $3.86 $3.93 $3.73 $3.93 696 788
2022-01-07 $4.10 $4.15 $3.87 $3.89 667 266
2022-01-06 $3.97 $4.16 $3.90 $4.12 895 700
2022-01-05 $4.25 $4.31 $3.99 $3.99 784 016
2022-01-04 $4.59 $4.64 $4.17 $4.19 1 063 532
2022-01-03 $4.45 $4.53 $4.27 $4.49 745 867
2021-12-31 $4.24 $4.45 $4.22 $4.33 642 763
2021-12-30 $4.47 $4.57 $4.38 $4.40 849 193
2021-12-29 $4.31 $4.53 $4.27 $4.47 956 956
2021-12-28 $4.25 $4.38 $4.23 $4.34 959 963
2021-12-27 $4.16 $4.33 $4.08 $4.23 1 380 287
2021-12-23 $4.08 $4.31 $4.08 $4.22 2 034 228
2021-12-22 $3.81 $4.14 $3.74 $4.05 3 973 353
2021-12-21 $5.05 $5.06 $3.68 $3.87 15 422 051
2021-12-20 $6.33 $6.51 $5.89 $6.45 1 189 599
2021-12-17 $6.20 $6.75 $6.02 $6.39 4 797 266
2021-12-16 $6.70 $6.75 $6.30 $6.32 854 405
2021-12-15 $6.10 $6.71 $6.04 $6.68 1 914 224
2021-12-14 $6.35 $6.35 $5.84 $6.05 1 123 338
2021-12-13 $6.33 $6.51 $6.12 $6.45 1 252 950
2021-12-10 $6.20 $6.43 $6.20 $6.29 991 440
2021-12-09 $6.26 $6.47 $6.13 $6.20 1 138 141
2021-12-08 $5.79 $6.27 $5.69 $6.26 856 799
2021-12-07 $5.76 $5.97 $5.75 $5.82 552 569
2021-12-06 $6.60 $6.60 $5.44 $5.73 1 125 382
2021-12-03 $6.94 $6.97 $6.61 $6.61 828 299
2021-12-02 $6.67 $6.91 $6.62 $6.90 876 142
2021-12-01 $6.70 $6.88 $6.64 $6.70 1 168 250
2021-11-30 $6.52 $6.89 $6.42 $6.61 2 274 572
2021-11-29 $6.74 $6.79 $6.49 $6.52 1 002 692
2021-11-26 $6.95 $6.96 $6.74 $6.75 829 123
2021-11-24 $7.15 $7.15 $6.94 $7.04 615 446
2021-11-23 $7.26 $7.29 $7.02 $7.21 1 255 933
2021-11-22 $7.33 $7.46 $7.17 $7.31 756 395
2021-11-19 $7.13 $7.35 $7.10 $7.34 783 448
2021-11-18 $7.30 $7.34 $7.01 $7.22 1 147 328
2021-11-17 $7.35 $7.53 $7.26 $7.37 896 423
2021-11-16 $7.20 $7.46 $7.06 $7.39 835 275
2021-11-15 $7.16 $7.41 $7.10 $7.26 953 729

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops novel class of antibody therapeutics based on its Probody technology platform that address clinically-validated cancer targets in immuno-oncology, such as PD-L1, as well as novel targets, comprising CD-166. In addition, it has strategic collaborations with Bristol-Myers Squibb Company, Pfizer Inc., ImmunoGen, Inc., and Th... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 108 000+ Happy Subscribers

Don't miss out on the runners!

Sign for StockInvest.us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT